PLAU was found to promote esophageal squamous cell carcinoma progression by the conversion of fibroblasts into inflammatory CAFs via uPAR/Akt/NF-κB/IL8 pathway (50). Here, PLAUR is linked to esophageal squamous cell carcinoma.